首页|期刊导航|中国神经再生研究(英文版)|Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
Monika Barczewska Mariusz Grudniak Stanis(l)aw Maksymowicz Tomasz Siwek Tomasz Oldak Katarzyna Jezierska-Wo(z)niak Dominika G(l)adysz Wojciech Maksymowicz
中国神经再生研究(英文版)2019,Vol.14Issue(2):313-318,6.
中国神经再生研究(英文版)2019,Vol.14Issue(2):313-318,6.DOI:10.4103/1673-5374.243723
Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
摘要
关键词
amyotrophic lateral sclerosis/stem cells therapy/intrathecal injections/Wharton's jelly-derived mesenchymal stem cells/adverse events/safety/cerebrospinal fluid/neural regenerationKey words
amyotrophic lateral sclerosis/stem cells therapy/intrathecal injections/Wharton's jelly-derived mesenchymal stem cells/adverse events/safety/cerebrospinal fluid/neural regeneration分类
医药卫生引用本文复制引用
Monika Barczewska,Mariusz Grudniak,Stanis(l)aw Maksymowicz,Tomasz Siwek,Tomasz Oldak,Katarzyna Jezierska-Wo(z)niak,Dominika G(l)adysz,Wojciech Maksymowicz..Safety of intrathecal injection of Wharton's jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy[J].中国神经再生研究(英文版),2019,14(2):313-318,6.基金项目
This research was supported by Instytut Terapii Komórkowych w Olsztynie (Cell Therapies Institute,FamiCord Group) in Olsztyn (to MB,SM,and TS). (Cell Therapies Institute,FamiCord Group)